Measurement of dissolved CO2 has critical applications in healthcare monitoring and consumer goods quality control, yet is difficult to measure directly.
Stanford researchers have developed a novel electrode composed of copper-based catalyst and a carbon-based catalyst to directly convert CO2 into ethylene, a valuable carbon-based molecule.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Researchers in the Wyss-Coray Lab are investigating a potential therapeutic antibody to treat lysosomal storage disorders and other related neurodegenerative diseases.
Stanford researchers have developed a method to form orthogonal overlapping joints at the 4 corners of the starting square. In order to have constant height of each beam, inserts in the beams between the joints will be required.
Researchers at Stanford have modified the spatial construction of two-wave interferometers to enable high-precision acoustic sensors and accelerometers produced at scale.
Researchers in the Roncarolo have discovered transcription factors that enable the tracking and differentiation of type 1 T regulatory (Tr1) cells for the treatment of autoimmune conditions.
Researchers at Stanford have developed a CRISPR-based system to degrade viral RNA, with potential applications as both an anti-viral therapeutic and a prophylactic treatment against influenza, SARS-CoV-2, and other viruses.
Researchers at Stanford have developed a potentially curative treatment strategy for alpha-thalassemia, one of the most common autosomal recessive disorders in the world involving the genes HBA1 and/or HBA2.
Stanford inventors have engineered an adeno-associated virus (AAV) variant on the existing LK03 platform that enables this highly efficient primate-specific serotype for use in rodent preclinical studies.